0.05% cyclosporine eye drops(Ⅱ)combined with sodium hyaluronate eye drops in the treatment of moderate to severe dry eye associated with diabetes mellitus
10.3980/j.issn.1672-5123.2025.6.03
- VernacularTitle:0.05%环孢素滴眼液(Ⅱ)联合玻璃酸钠滴眼液治疗糖尿病合并中重度干眼
- Author:
Cancan SHI
1
,
2
;
Xinshu LIU
1
,
2
;
Shuwen CHEN
1
,
2
;
Yingyi ZHAO
1
,
2
;
Xiaofan YU
1
,
2
;
He WANG
1
,
2
;
Mingxin LI
1
,
2
Author Information
1. Graduate School, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
2. Department of Ophthalmology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China
- Publication Type:Journal Article
- Keywords:
dry eye;
diabetes mellitus;
0.05% cyclosporine eye drops(Ⅱ);
sodium hyaluronate eye drops;
ocular surface;
inflammatory factors;
corneal nerves;
clinical efficacy
- From:
International Eye Science
2025;25(6):886-893
- CountryChina
- Language:Chinese
-
Abstract:
AIM:To evaluate the clinical efficacy of 0.05% cyclosporine eye drops(Ⅱ)combined with sodium hyaluronate eye drops in treating patients with type 2 diabetes mellitus(T2DM)and moderate-to-severe dry eye.METHODS:A total of 120 T2DM patients(120 eyes)with moderate-to-severe dry eye, treated at the endocrinology and ophthalmology departments at the Affiliated Hospital of Xuzhou Medical University from January 2024 to September 2024, were enrolled in the study. The patients were randomly divided into two groups: combination group [0.05% cyclosporine eye drops(Ⅱ)+ sodium hyaluronate eye drops] and control group(sodium hyaluronate eye drops alone), with 60 cases(60 eyes)in each group. Assessments were conducted at baseline and at 1, 2, and 3 mo post-treatment, including the ocular surface disease index(OSDI), non-contact tear meniscus height(NITMH), first non-invasive tear breakup time(NIBUTf), meibomian gland loss score, lipid layer thickness grade, conjunctival hyperemia grade, and corneal fluorescein staining(FL)score. At 3 mo after treatment, changes in tear inflammatory factors were observed, and corneal subbasal nerve plexus(SBN)morphology/density were analyzed using in vivo confocal microscopy(IVCM).RESULTS:At 1, 2, and 3 mo post-treatment, both groups showed statistically significant increases in NITMH and NIBUTf compared to baseline(all P<0.05), with greater improvement observed in the combination group(both P<0.05). OSDI and FL scores significantly decreased from baseline(all P<0.05), with more pronounced reductions in the combination group(both P<0.05). Meibomian gland loss scores showed no significant improvement in either group(all P>0.05). At 3 mo after treatment, tear levels of interleukin 6(IL-6)and matrix metalloproteinase-9(MMP-9)significantly decreased in both groups(all P<0.001), with a greater reduction noted in the combination group(both P<0.001). The combination group displayed increased corneal nerve branch density and nerve fiber density, along with decreased nerve tortuosity and dendritic cell(DC)density compared to baseline(all P<0.001), while the control group did not show significant changes(all P>0.05).CONCLUSION: The combination of 0.05% cyclosporine eye drops(Ⅱ)and sodium hyaluronate eye drops significantly improves clinical outcomes in T2DM patients with moderate-to-severe dry eye. This treatment effectively alleviates ocular surface inflammation, restores corneal nerve morphology and density, and demonstrates a favorable safety profile.
